Reuben Harris, PhD, to chair Department of Biochemistry and Structural Biology

March 11, 2022

Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 11, 2021) — Cancer and virology researcher Reuben Harris, PhD, has been named chairman of the Department of Biochemistry and Structural Biology at The University of Texas Health Science Center at San Antonio (UT Health San Antonio). The department is in the Joe R. and Teresa Lozano […]

Microscope in laboratory


Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

March 10, 2022

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio together with SignalRx Pharmaceuticals Inc. have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division […]




Thoracic surgery team achieves highly coveted ranking for lung, esophageal cancer outcomes

March 10, 2022

Only the most elite programs garner 3-star ratings from the Society of Thoracic Surgeons. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 10, 2022) — The UT Health San Antonio Department of Cardiothoracic Surgery has earned a distinguished three-star rating from the Society of Thoracic Surgeons (STS) for its patient care and lung and […]

Photo of surgery




Mays Cancer Center studies help spur leukemia drug’s approval

March 1, 2022

The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Tuesday, March 1, 2022) — Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib […]

Cancer Patient with Cap Photo